Management of Arrhythmias Associated with COVID-19.
PURPOSE OF REVIEW
Cardiac arrhythmias are known complications in patients with COVID-19 infection that may persist even after recovery from infection. A review of the spectrum of cardiac arrhythmias due to COVID-19 infection and current guidelines and assessment or risk and benefit of management considerations is necessary as the population of patients infected and covering from COVID-19 continues to grow.


RECENT FINDINGS
Cardiac arrhythmias such as atrial fibrillation, supraventricular tachycardia, complete heart block, and ventricular tachycardia occur in patients infected, recovering and recovered from COVID-19. Personalized care while balancing risk/benefit of medical or invasive therapy is necessary to improve care of patients with arrhythmias. Providers must provide thorough follow-up care and use necessary precaution while caring for COVID-19 patients.
['Desai|Amar D|AD|', 'Boursiquot|Brian C|BC|', 'Melki|Lea|L|', 'Wan|Elaine Y|EY|http://orcid.org/0000-0002-5328-7282']
D001281:Atrial Fibrillation D000086382:COVID-19 D006801:Humans D058873:Pandemics D000086402:SARS-CoV-2 D013617:Tachycardia, Supraventricular
COVID-19 Cardiac arrhythmias Sars-CoV-2